The Puzzle-Solving CEO

This episode of Molecule to Market explores the dynamic world of global drug development with our SaniSure CEO, Steven Chevillotte.
  • SaniSure’s unique positioning in the bioprocessing landscape and how it stands out from both smaller and larger organizations
  • How SaniSure built powerful partnerships through professionalization and integration, while preserving the entrepreneurial spirit and innovative DNA of its’ founders
  • The evolution of high-quality components and complex assemblies into breakthrough systems and solutions
  • Strengthening the bioprocessing supply chain for greater reliability and efficiency